Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
Clinician,"Adalimumab, etanercept and secukinumab","Psoriatic arthritis, remove SA criteria relating to CRP","Adalimumab, etanercept and secukinumab",Community and Hospital,Oncology Agents and Immunosuppressants
